AFP12h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Opinion
Hosted on MSN4hOpinion
5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era
The biotech industry has declined since Donald Trump’s election victory. This was mainly because Trump nominated Robert F. Kennedy Jr., a vaccine skeptic, to head the Health and Human Services, the ...
Budget 2025 expectations highlights: What India wants from FM Nirmala Sitharaman on February 1
The Union Budget 2025, the second full budget of Modi 3.0 may bring multiple changes such as income tax reforms, an increased focus on agriculture, and balancing between fiscal consolidation and econo ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
University of Minnesota, Mayo study uncovers new link between infections and heart failure
Study of more than 14,000 people from Minneapolis and three other U.S. sites transcended five decades in its search for heart ...
Are taller people more prone to cancer? Beware of the signs
Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...